Interleukin-7 induced facilitation of immunological reconstitution of sublethally irradiated mice following treatment with alloreactive spleen cells in a murine model of B-cell leukemia/lymphoma (BCL1)

Bone Marrow Transplantation

Volumn 40, Issue 9, 2007, Pages 881-889

  Abdul Hai, A ^a   Weiss, L ^a   Ben Yehuda, A ^b   Ergas, D ^b   Shapira, M Y ^a   Slavin, S ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; RECOMBINANT INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 7;

ADOPTIVE TRANSFER; ALLOGENEIC STEM CELL TRANSPLANTATION; ALLOIMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B CELL LEUKEMIA; B CELL LYMPHOMA; CANCER SURVIVAL; CELL POPULATION; CELL PROLIFERATION; CHIMERA; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DISEASE FREE SURVIVAL; GRAFT VERSUS LEUKEMIA EFFECT; IMMUNOSTIMULATION; IN VITRO STUDY; IN VIVO STUDY; IRRADIATION; MINIMAL RESIDUAL DISEASE; MONOTHERAPY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; SURVIVAL RATE; SURVIVAL TIME; T LYMPHOCYTE; THYMOCYTE;

ADOPTIVE TRANSFER; ANIMALS; CELL TRANSPLANTATION; DISEASE MODELS, ANIMAL; DISEASE-FREE SURVIVAL; GRAFT VS LEUKEMIA EFFECT; HUMANS; IMMUNE SYSTEM; INTERLEUKIN-7; LEUKEMIA, B-CELL; LYMPHOMA, B-CELL; MICE; MICE, INBRED STRAINS; REGENERATION; SPLEEN; TRANSPLANTATION, HOMOLOGOUS;

EID: 35649022660     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705819     Document Type: Article

References (21)

1. Truitt R, Johnson B, McCabe C, Weiler M. Graft-versus-leukemia. In: Ferrara J, Deeg H, Bukaroff S (eds). Graft-vs-Host Disease, 2nd edn. Marcel Dekker Inc.: New York, 1997, pp 385-424.
2. Barnes DHW, Loutit JF. Treatment of murine leukaemia with x-rays and homologous bone marrow. II. Br J Haematol 1957; 3: 241-251.
3. Mathé G, Amiel JL, Schwarzenberg L, Cattan A, Schneider M, Devries MJ et al. Successful allogeneic bone marrow transplantation in man: chimerism, induced specific tolerance and possible antileukemic effects. Blood 1965; 25: 170.
4. Weiden PL, Sullivan KM, Flournoy N, Storb R, Thomas ED. Anti-leukemic effect of chronic graft-versus-host-disease: Contribution to improved survival after allogeneic marrow transplantation. N Engl J Med 1981; 304: 1529-1531.
5. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ et al. Graft-versus-leukemia reactions after bone marrow transplantation. Blood 1990; 75: 555-562.
6. Fry TJ, Mackall CL. Interleukin-7: From bench to clinic. Blood 2002; 99: 3892-3904.
7. Sempowski GD, Gooding ME, Liao HX, Le PT, Haynes BF. T cell receptor excision circle assessment of thymopoiesis in aging mice. Mol Immunol 2002; 38: 841-848.
8. Bolotin E, Smogorzewska M, Smith S, Widmer M, Weinberg K. Enhancement of thymopoiesis after bone marrow transplant by in vivo interleukin-7. Blood 1996; 88: 1887-1894.
9. Okamoto Y, Douek DC, McFarland RD, Koup RA. Effects of exogenous interleukin-7 on human thymus function. Blood 2002; 99: 2851-2858.
10. Geiselhart LA, Humphries CA, Gregorio TA, Mou S, Subleski J, Komschlies KL. IL-7 administration alters the CD4:CD8 ratio, increases T cell numbers, and increases T cell function in the absence of activation. J Immunol 2001; 166: 3019-3027.
11. Lynch DH, Miller RE. Interleukin 7 promotes long-term in vitro growth of antitumor cytotoxic T lymphocytes with immunotherapeutic efficacy in vivo. J Exp Med 1994; 179: 31-42.
12. Wiryana P, Bui T, Faltynek CR, Ho RJ. Augmentation of cell-mediated immunotherapy against herpes simplex virus by interleukins: Comparison of in vivo effects of IL-2 and IL-7 on adoptively transferred T cells. Vaccine 1997; 15: 561-563.
13. Abdul-Hai A, Or R, Slavin S, Friedman G, Weiss L, Matsa D et al. Stimulation of immune reconstitution by interleukin-7 after syngeneic bone marrow transplantation in mice. Exp Hematol 1996; 24: 1416-1422.
14. Alpdogan O, Schmaltz C, Muriglan SJ, Kappel BJ, Perales MA, Rotolo JA et al. Administration of interleukin-7 after allogeneic bone marrow improves immune reconstitution without aggravating graft-versus-host disease. Blood 2001; 98: 2256-2265.
15. Mackall CL, Fry TJ, Bare C, Morgan P, Galbraith A, Gress RE. IL-7 increases both thymic-dependent and thymic-independent T-cell regeneration after bone marrow transplantation. Blood 2001; 97 1491-1497.
16. Slavin S, Strober S. Spontaneous murine B-cell leukaemia. Nature 1978; 272: 624-626.
17. Aversa F, Tabilio A, Velardi A, Cunningham I, Terenzi A, Falzetti F et al. Treatment of high-risk acute leukemia with T-cell-depleted stem cells from related donors with one fully mismatched HLA haplotype. N Engl J Med 1998; 339: 1186-1193.
18. Aversa F, Velardi A, Tabilio A, Reisner Y, Martelli MF. Haploidentical stem cell transplantation in leukemia. Blood Rev 2001; 15: 111-119.
19. Or R, Abdul-Hai A, Ben-Yehuda A. Reviewing the potential utility of interleukin-7 as a promoter of thymopoiesis and immune recovery. Cytokines Cell Mol Ther 1998; 4: 287-294. Review.
20. Abdul-Hai A, Weiss L, Slavin S, Or R. Improved survival following induction of GVHD following lipopolysaccharide immunization. Exp Hematol 2006; 34: 549-553.
21. + T cells in immunotherapy for leukemia. Cytokines Cell Mol Ther 1599; 5: 153-158.